EV Biologics, Inc. (YECO)
OTCMKTS · Delayed Price · Currency is USD
0.0907
+0.0085 (10.31%)
At close: Feb 5, 2026
EV Biologics Market Cap
EV Biologics has a market cap or net worth of $927.19 thousand as of February 9, 2026. Its market cap has decreased by -90.35% in one year.
Market Cap
927.19K
Enterprise Value
n/a
Revenue
9.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since June 29, 2015, EV Biologics's market cap has decreased from 70.39M to 927.19K, a decrease of -98.68%. That is a compound annual growth rate of -33.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 927.19K | 11.81% |
| Dec 31, 2025 | 829.28K | -15.08% |
| Dec 31, 2024 | 976.52K | -90.45% |
| Dec 20, 2023 | 10.23M | -56.18% |
| Dec 28, 2022 | 23.33M | 109.88% |
| Dec 31, 2021 | 11.12M | -83.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZyVersa Therapeutics | 1.30M |
| CERo Therapeutics Holdings | 1.28M |
| Sigyn Therapeutics | 1.20M |
| Halberd | 1.20M |
| Evofem Biosciences | 1.18M |
| Emmaus Life Sciences | 975.62K |
| Lipella Pharmaceuticals | 881.43K |
| Eastgate Biotech | 846.29K |